Article Information
History
- April 22, 2024.
Article Versions
- You are currently viewing Version 1 of this article (April 22, 2024 - 20:54).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Flávia Eichemberger Rius1,2,
- Rodrigo Guindalini3,
- Danilo Viana1,
- Júlia Salomão1,
- Laila Gallo1,
- Renata Freitas1,
- Cláudia Bertolacini1,
- Lucas Taniguti1,
- Danilo Imparato1,
- Flávia Antunes1,
- Gabriel Sousa1,
- Renan Achjian1,
- Eric Fukuyama1,
- Cleandra Gregório1,
- Iuri Ventura1,
- Juliana Gomes1,
- Nathália Taniguti1,
- Simone Maistro2,
- José Eduardo Krieger4,
- Yonglan Zheng5,
- Dezheng Huo6,
- Olufunmilayo I. Olopade5,
- Maria Aparecida Koike2 and
- David Schlesinger1,*
- 1Mendelics, São Paulo, Brazil
- 2Comprehensive Center for Precision Oncology - C2PO, Centro de Investigação Translacional em Oncologia (CTO), Departamento de Radiologia e Oncologia, Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
- 3Instituto D’Or de Pesquisa e Ensino (IDOR), São Paulo, Brazil
- 4Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - FMUSP, São Paulo, Brazil
- 5Medicine and Human Genetics, Center for Clinical Cancer Genetics and Global Health, University of Chicago Medical Center, Chicago, USA
- 6Department of Public Health Sciences, University of Chicago, Chicago, USA
- ↵* Corresponding author; email: david{at}mendelics.com.br
Posted April 22, 2024.
A Breast Cancer Polygenic Risk Score Validation in 15,490 Brazilians using Exome Sequencing
